+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ISERA ISERA

iSERA Lifesciences Share Price

₹143.90 +0 (0%)
New 52W High today

01 Sep, 2026 4:01 PM (IST)

iSERA Lifesciences live price: ₹143.90. It opened at ₹144 vs previous close ₹144; intraday high/low: ₹144/₹144. The 50 & 200 DMA stand at ₹132.00/₹77.60.

iSERA Lifesciences Performance

  • Today's Low
  • ₹144
  • Today's High
  • ₹144
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹144
  • Open Price₹144
  • Previous Close₹144
  • Volume3
  • 50 DMA₹132.00
  • 100 DMA₹108.80
  • 200 DMA₹77.60

iSERA Lifesciences Chart

Investment Returns

  • Over 1 Month + 0%
  • Over 3 Month + 52.81%
  • Over 6 Month + 257.6%
  • Over 1 Year + 2274.59%

Smart Investing Starts Here Start SIP with iSERA Lifesciences for Steady Growth!

Invest Now

iSERA Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 466.5
  • PEG Ratio
  • -3.2
  • Market Cap Cr
  • 121
  • P/B Ratio
  • 15.3
  • Average True Range
  • 0.2
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.1
  • RSI
  • 100
  • MFI
  • -

Latest Stock News Updates

iSERA Lifesciences Ltd - 534920 - Reg. 34 (1) Annual Report.

we hereby submit Annual Report of Annual General Meeting of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) for the financial year 2025-26

iSERA Lifesciences Ltd - 534920 - Notice Of 34Th Annual General Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Financial Year 2025-26

Notice of 34th Annual General Meeting ('AGM') of the Company is scheduled to be held on Tuesday, September 29, 2026 at 3:00 P.M. (IST) through video conference ('VC')/ other audio visual means ('OAVM') in compliance with the applicable provisions of the Companies Act, 2013 and rules made thereunder and the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and relevant circulars issued by MCA and SEBI.

iSERA Lifesciences Ltd - 534920 - Announcement under Regulation 30 (LODR)-Newspaper Publication

iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) has filed with the exchange copy of newspaper publication.

iSERA Lifesciences Financials

iSERA Lifesciences Technicals

EMA & SMA

Current Price
₹143.90
0 (0%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹143.10
  • 50 Day
  • ₹132.00
  • 100 Day
  • ₹108.80
  • 200 Day
  • ₹77.60

Resistance and Support

143.9 Pivot Speed
  • R3 143.90
  • R2 143.90
  • R1 143.90
  • S1 143.90
  • S2 143.90
  • S3 143.90

iSERA Lifesciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-07 Quarterly Results
2026-05-21 Audited Results
2026-04-20 Preferential issue of shares
2026-02-10 Quarterly Results
2025-11-13 Quarterly Results

iSERA Lifesciences Shareholding Pattern

58.63%
41.37%
0%

About iSERA Lifesciences

Covidh Technologies domain and technology expertise has been built over last 5 years through a unique combination of long standing customer relationships, investments in people and through continuous investments in new technologies. View More
  • NSE Symbol
  • ISERA
  • BSE Symbol
  • 534920
  • ISIN
  • INE899M01020

Similar Stocks to iSERA Lifesciences

iSERA Lifesciences FAQs

iSERA Lifesciences share price is ₹143 As on 06 September, 2026 | 18:14

The Market Cap of iSERA Lifesciences is ₹121 Cr As on 06 September, 2026 | 18:14

The P/E ratio of iSERA Lifesciences is 466.5 As on 06 September, 2026 | 18:14

The PB ratio of iSERA Lifesciences is 15.3 As on 06 September, 2026 | 18:14

The 52 week High & Low of iSERA Lifesciences is ₹143.9/₹6.2 respectively As on 06 September, 2026 | 18:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23